These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 23506416)

  • 21. Impact of hepatitis C virus eradication with direct-acting antivirals on glycidic metabolism.
    Sparvoli JMH; Sparvoli AC; de Carvalho Dumith S; Pereira AA; de Paula ALM; Garcia L; Belarmino V; da Hora VP; de Martínez AMB; Gonçalves CV
    Arch Endocrinol Metab; 2023 Mar; 67(3):314-322. PubMed ID: 36468927
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Study of prevalence and effects of insulin resistance in patients with chronic hepatitis C genotype 4.
    Amer AF; Baddour MM; Elshazly MA; Fadally G; Hanafi NF; Assar SL
    East Mediterr Health J; 2016 Feb; 21(11):803-10. PubMed ID: 26857717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of insulin resistance on the development of hepatocellular carcinoma after antiviral treatment for non-cirrhotic patients with chronic hepatitis C.
    Hayashi T; Ogawa E; Furusyo N; Murata M; Hayashi J
    Infect Agent Cancer; 2016; 11():9. PubMed ID: 26913058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin resistance in chronic hepatitis C.
    Yazicioglu G; Isitan F; Altunbas H; Suleymanlar I; Ozdogan M; Balci MK; Karayalcin U
    Int J Clin Pract; 2004 Nov; 58(11):1020-2. PubMed ID: 15605664
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence of oxidative stress as a cofactor in the development of insulin resistance in patients with chronic hepatitis C.
    Mitsuyoshi H; Itoh Y; Sumida Y; Minami M; Yasui K; Nakashima T; Okanoue T
    Hepatol Res; 2008 Apr; 38(4):348-53. PubMed ID: 18021228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of HCV treatment response on insulin resistance: A systematic review and meta-analysis.
    Hu JH; Chang ML; Liu NJ; Yeh CT; Huang TJ
    Exp Ther Med; 2019 Nov; 18(5):3568-3578. PubMed ID: 31602234
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diabetes mellitus, insulin resistance and hepatitis C virus infection: A contemporary review.
    Desbois AC; Cacoub P
    World J Gastroenterol; 2017 Mar; 23(9):1697-1711. PubMed ID: 28321170
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of IRS-1 by hepatitis C virus infection leads to insulin resistance in a PTEN-dependent manner.
    Gao TT; Qin ZL; Ren H; Zhao P; Qi ZT
    Virol J; 2015 Feb; 12():12. PubMed ID: 25645159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of insulin resistance on sustained response in HCV patients treated with pegylated interferon and ribavirin: a meta-analysis.
    Deltenre P; Louvet A; Lemoine M; Mourad A; Fartoux L; Moreno C; Henrion J; Mathurin P; Serfaty L
    J Hepatol; 2011 Dec; 55(6):1187-94. PubMed ID: 21703195
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis C virus induced insulin resistance impairs response to anti viral therapy.
    El-Zayadi AR; Anis M
    World J Gastroenterol; 2012 Jan; 18(3):212-24. PubMed ID: 22294824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Alcohol, metabolic syndrome and obesity: impact on treatment efficacy].
    Serfaty L; Mathurin P; Cadranel JF; Tran A
    Gastroenterol Clin Biol; 2007; 31(8-9 Pt 3):4S40-3. PubMed ID: 17965634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sustained virological response following chronic hepatitis C treatment is associated with improvement in insulin resistance.
    Chan CH; Hansen RD; Gilliver RS; Jones BE
    Intern Med J; 2013 Jun; 43(6):656-62. PubMed ID: 23506416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adipokines and insulin resistance, predictors of response to therapy in Egyptian patients with chronic hepatitis C virus genotype 4.
    Saad Y; Ahmed A; Saleh DA; Doss W
    Eur J Gastroenterol Hepatol; 2013 Aug; 25(8):920-5. PubMed ID: 23442415
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Time course of insulin resistance during antiviral therapy in non-diabetic, non-cirrhotic patients with genotype 1 HCV infection.
    Petta S; Cammà C; Di Marco V; Cabibi D; Ciminnisi S; Caldarella R; Licata A; Massenti MF; Marchesini G; Craxì A
    Antivir Ther; 2009; 14(5):631-9. PubMed ID: 19704165
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.